In a straightforward approach, we treated MRL/MpJ mice with poly I:C-induced AIP with the MAP3K7 inhibitor takinib [14] and the JAK inhibitor tofacitinib, which preferentially inhibits the expression of Bach2-regulated pro-inflammatory genes [16]. Here, MAP3K7 is linked to autoimmune pancreatitis.